NCT04580069

Brief Summary

The investigators studied the influence of two aproved rehabilitative treatments, connective tissue techniques and lymphatic drainage, on acute inflammation markers. Furthermore, the role of mediterranean diet on the same values was investigated in the first postoperative period

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2019

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 30, 2019

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

September 30, 2020

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 8, 2020

Completed
Last Updated

October 8, 2020

Status Verified

October 1, 2020

Enrollment Period

1 year

First QC Date

September 30, 2020

Last Update Submit

October 7, 2020

Conditions

Keywords

total Knee Arthroplasty (TKA)C-reactive protein (CRP)erythrosedimentation rate (ESR)Over Knee Oedema (EDO)Under Knee Oedema (EDU)MEDIET Questionnaire

Outcome Measures

Primary Outcomes (3)

  • CRP variation

    blood test

    21 days

  • ESR variation

    blood test

    21 days

  • lower limb oedema

    leg circumference

    21 days

Study Arms (3)

Lymphatic drainage

EXPERIMENTAL

Patients subjected to manual lymphatic drainage

Procedure: Lymphatic drainage

Connective tissue

EXPERIMENTAL

Patients subjected to connective tissue massage

Procedure: Lymphatic drainage

control group

ACTIVE COMPARATOR

Subjects hat followed standard rehabilitative treatment

Procedure: Lymphatic drainage

Interventions

The interventions follow the validated techniques normally used in international rehabilitation

Also known as: Connective tissue massage
Connective tissueLymphatic drainagecontrol group

Eligibility Criteria

Age50 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \<age\<80 years
  • Bicompartmental knee arthroplasty
  • Weight bearing 7 days after surgery
  • Transfusions according to hospital protocol
  • Alteration of the indices at T0
  • Standard analgesic therapy

You may not qualify if:

  • Joint replacements from other Units
  • Inflammatory arthropathies
  • Autoimmune / rheumatic diseases
  • Obesity
  • Diabetes mellitus
  • Infections

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

presidio ospedaliero di Asiago

Asiago, Vicenza, 36012, Italy

Location

ULSS 7 Pedemontana

Asiago, Vicenza, 36012, Italy

Location

Related Publications (1)

  • Rigoni S, Tagliaro L, Bau D, Scapin M. Effectiveness of two rehabilitation treatments in the modulation of inflammation during the acute phase in patients with knee prostheses and assessment of the role of the diet in determining post-surgical inflammation. J Orthop. 2021 May 15;25:237-243. doi: 10.1016/j.jor.2021.05.016. eCollection 2021 May-Jun.

MeSH Terms

Interventions

Manual Lymphatic Drainage

Intervention Hierarchy (Ancestors)

MassageTherapy, Soft TissueMusculoskeletal ManipulationsComplementary TherapiesTherapeuticsDrainagePhysical Therapy ModalitiesRehabilitation

Study Officials

  • Sergio Rigoni

    Presidio Ospedaliero di Asiago

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized Controlled Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Sergio Rigoni

Study Record Dates

First Submitted

September 30, 2020

First Posted

October 8, 2020

Study Start

September 30, 2019

Primary Completion

September 30, 2020

Study Completion

September 30, 2020

Last Updated

October 8, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

Locations